Soren L Kristensen
Overview
Explore the profile of Soren L Kristensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1664
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Begun X, Butt J, Kristensen S, Weeke P, De Backer O, Strange J, et al.
Am Heart J
. 2023 May;
264:183-189.
PMID: 37178995
Background: Valve-in-valve-transcatheter aortic valve implantation (TAVI) is a feasible and increasingly used treatment option for failed surgical aortic prosthesis, but data from clinical practice are limited. We aimed to examine...
12.
Kristensen S, Jensen J, Schou M
J Am Coll Cardiol
. 2023 May;
81(19):1915-1917.
PMID: 37164524
No abstract available.
13.
Westergaard L, Alhakak A, Rorth R, Fosbol E, Kristensen S, Svendsen J, et al.
Europace
. 2023 Apr;
25(5).
PMID: 37083042
Aims: While clinical trials have suggested that a high ventricular rate is associated with increased risk of heart failure (HF) and mortality, all-comers studies are warranted. Objective: To assess 1-year...
14.
Sun G, Faurschou M, Vinding N, Yafasova A, Kristensen S, Ahlehoff O, et al.
Eur J Prev Cardiol
. 2023 Feb;
30(13):1308-1314.
PMID: 36821709
Aims: Autoimmune diseases (AIDs) are associated with a higher risk of heart failure (HF). However, data on the prognosis of HF patients with a history of AID are limited. The...
15.
Lauridsen M, Rorth R, Butt J, Strange J, Schmidt M, Kristensen S, et al.
Eur Heart J Qual Care Clin Outcomes
. 2022 Dec;
9(7):707-715.
PMID: 36509229
Aims: Myocardial infarction (MI) with cardiogenic shock (CS) and/or out-of-hospital cardiac arrest (OHCA) are conditions with potential loss of autonomy. In patients with MI, the association between CS and OHCA...
16.
Lauridsen M, Rorth R, Butt J, Schmidt M, Weeke P, Kristensen S, et al.
Eur Heart J Acute Cardiovasc Care
. 2022 Apr;
11(5):397-406.
PMID: 35425972
Background: Physical and mental well-being after critical illness may be objectified by the ability to work. We examined return to work among patients with myocardial infarction (MI) by cardiogenic shock...
17.
Vinding N, Kristensen S, Rorth R, Butt J, Ostergaard L, Olesen J, et al.
J Am Heart Assoc
. 2022 Feb;
11(4):e022638.
PMID: 35156393
Background Our objective was to investigate stroke severity and subsequent rate of mortality among patients with and without atrial fibrillation (AF). Contemporary data on stroke severity and prognosis in patients...
18.
Lee M, Kristensen S, Gerstein H, McMurray J, Sattar N
Diabetes Metab Syndr
. 2022 Jan;
16(1):102382.
PMID: 35030451
Background And Aims: FREEDOM, a cardiovascular outcome trial with a GLP-1 receptor agonist, testing a continuous subcutaneous infusion of exenatide (ITCA 650), recently reported its findings. Methods: We meta-analysed its...
19.
Larsson J, Kristensen S, Madelaire C, Schou M, Rossing K, Boesgaard S, et al.
Circ Heart Fail
. 2021 Aug;
14(10):e008662.
PMID: 34461745
Background: Factors determining referral for advanced heart failure (HF) evaluation are poorly studied. We studied the influence of socioeconomic aspects on the referral process in Denmark, which has a taxpayer-funded...
20.
Sattar N, Lee M, Kristensen S, Branch K, Del Prato S, Khurmi N, et al.
Lancet Diabetes Endocrinol
. 2021 Aug;
9(10):653-662.
PMID: 34425083
Background: GLP-1 receptor agonists reduce major adverse cardiovascular events (MACE) in patients with type 2 diabetes. However, uncertainty regarding kidney outcomes persists and whether benefits extend to exendin-4-based GLP-1 receptor...